Viewing nowNexgliptin 50 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Bynex Co., Ltd.

MFDS item code 202005611 · Approved 2020.08.03 · Insurance code 643105720
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used in conjunction with dietary and exercise therapy to help patients with type 2 diabetes manage their blood sugar levels. Initially, it can be administered alone, and if blood sugar control is difficult with monotherapy, it may be used in combination with metformin. Additionally, if blood sugar control is insufficient with other antidiabetic medications such as sulfonylureas, thiazolidinediones, and insulin, this drug can be added to the regimen. These methods effectively improve blood sugar control in patients.
Whether used as monotherapy or in combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medication may be taken with or without food. When administered in combination with a sulfonylurea or insulin, consider reducing the dose of the sulfonylurea or insulin to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Assessment of renal function is recommended before treatment with this medication and periodically thereafter, as dose adjustment according to renal function is necessary. No dose adjustment is necessary in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dose adjustment is necessary in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or patients with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered regardless of the timing of dialysis.
This medication may cause allergic reactions; if symptoms such as skin rash or difficulty breathing occur after taking the medication, discontinue use immediately and consult a doctor. This medication may cause severe inflammation of the pancreas known as pancreatitis, so if abdominal pain, nausea, or vomiting occurs while taking it, seek medical attention immediately. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis. Patients with impaired kidney function may need dosing adjustments, and should follow the doctor's instructions based on kidney function test results. Be cautious of hypoglycemic symptoms while taking this medication, especially when used in combination with other hypoglycemic agents like insulin or sulfonylureas, as the risk of hypoglycemia may be increased. Side effects such as headaches, upper respiratory infections, nasopharyngitis, diarrhea, nausea, abdominal pain, constipation, vomiting, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, dyspepsia, dizziness, increased triglycerides, increased low-density lipoprotein, hyperglycemia, hypertension, weight loss, erectile dysfunction, and elevated liver enzymes may occur, so if symptoms persist or worsen, consult a doctor. Pregnant or breastfeeding women should avoid taking this medication, and safety in children under 18 has not been established. Older adults may have decreased kidney function, so it is important to regularly monitor kidney function before and after taking the medication. In cases of overdose, treatment may be necessary to remove the drug from the gastrointestinal tract and monitor the condition through electrocardiograms, and some drugs may be removed through hemodialysis. This medication generally has few interactions with specific drugs, but inform your doctor or pharmacist if you are taking other medications. If severe joint pain or skin blisters occur while taking this medication, inform your doctor immediately and discontinue use.
Severe hypersensitivity reactions, anaphylaxis, angioedema, Stevens-Johnson syndrome, exfoliative dermatitis, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe and disability-accompanied arthralgia, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevated liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, ideally at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Pale yellow-pink round, biconvex film-coated tablet
30 tablets - 10 tablets per PTPy [x3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Bynex Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.